{"id":"W2131398863","doi":"10.1200/jco.2007.14.0228","title":"Benefit From Exemestane As Extended Adjuvant Therapy After 5 Years of Adjuvant Tamoxifen: Intention-to-Treat Analysis of the National Surgical Adjuvant Breast and Bowel Project B-33 Trial","year":2008,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":340,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Exemestane; Medicine; Breast cancer; Tamoxifen; Adjuvant therapy; Internal medicine; Placebo; Oncology; Adjuvant; Letrozole; Aromatase inhibitor; Surgery; Cancer; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004037665,0.001577062,0.002871511,0.0005162174,0.0002888457,0.001013313,0.0006682417,0.001853566,0.005171027],"category_scores_gemma":[0.003855759,0.0004897591,0.003396244,0.0003254805,0.0008473247,0.001016745,0.0004311816,0.00302742,0.0006379003],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006013543,"about_ca_system_score_gemma":0.0009471821,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005318596,"about_ca_topic_score_gemma":0.001118005,"domain_scores_codex":[0.9973984,0.001985151,0.000086671,0.0001952993,0.0001079762,0.000226486],"domain_scores_gemma":[0.9984251,0.000664533,0.0003843202,0.0001652731,0.00006578525,0.0002949534],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9890733,0.00145857,0.0008291274,0.0002043628,0.001227855,0.00002873205,0.00002123257,0.0003455788,0.0005840239,0.00006557955,0.0002763289,0.005885284],"study_design_scores_gemma":[0.9416634,0.04880692,0.00521322,0.00006979885,0.001883574,0.00003955952,0.00001912394,0.001130418,0.0002792833,0.0003721638,0.0005061611,0.00001647734],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9835674,0.009208859,0.0008484561,0.0009337424,0.000579869,0.001738425,0.0007628303,0.0001044638,0.002256052],"genre_scores_gemma":[0.9931136,0.001578991,0.0006531075,0.0006928201,0.0003675559,0.001175126,0.000663537,0.00001574536,0.001739512],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005171027,"threshold_uncertainty_score":0.02135348,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06060764010099409,"score_gpt":0.4051019761763338,"score_spread":0.3444943360753397,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}